These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 6362870

  • 1. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S, Wittes R.
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract] [Full Text] [Related]

  • 2. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS.
    Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
    [Abstract] [Full Text] [Related]

  • 3. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract] [Full Text] [Related]

  • 4. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD, Greenwald P.
    Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
    [No Abstract] [Full Text] [Related]

  • 5. Developing new agents for the treatment of childhood cancer.
    Kurmasheva R, Morton C, Houghton PJ.
    Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
    [Abstract] [Full Text] [Related]

  • 6. The role of the National Cancer Institute in drug development.
    Doroshow J.
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract] [Full Text] [Related]

  • 7. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
    Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
    [No Abstract] [Full Text] [Related]

  • 8. Screening at the National Cancer Institute.
    Goldin A, Venditti JM, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract] [Full Text] [Related]

  • 9. Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations.
    Natl Cancer Inst Monogr; 1980 Dec; (55):1-179. PubMed ID: 7010179
    [No Abstract] [Full Text] [Related]

  • 10. Clinical test methods for antitumor drugs in the U.S.S.R.
    Garin AM, Lichinitser MR.
    Natl Cancer Inst Monogr; 1977 Mar; (45):227-33. PubMed ID: 337153
    [No Abstract] [Full Text] [Related]

  • 11. [Soviet-American cooperation in experimental and clinical chemotherapy from 1972 to 1979].
    Peredovchikova NI, Kiselev AV, Puchkov IuI, Komarova LE, Gorbunova VA.
    Vopr Onkol; 1980 Mar; 26(12):3-6. PubMed ID: 7008350
    [No Abstract] [Full Text] [Related]

  • 12. As memory serves--an informal history of the National Cancer Institute, 1937-57.
    Shimkin MB.
    J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):559-600. PubMed ID: 328903
    [No Abstract] [Full Text] [Related]

  • 13. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ, Young DM, Davis RD, Cooney DA, Guarino AM.
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract] [Full Text] [Related]

  • 14. Proceedings: Anticancer drug development programs: a comparison of approaches in the United States, the Soviet Union, Japan, and Western Europe.
    Carter SK.
    Natl Cancer Inst Monogr; 1974 Feb; 40():31-45. PubMed ID: 4819407
    [No Abstract] [Full Text] [Related]

  • 15. Basic cancer chemotherapy: experimental models--strategy.
    Mulder JH.
    Cancer Clin Trials; 1978 Feb; 1(2):129-34. PubMed ID: 391424
    [No Abstract] [Full Text] [Related]

  • 16. The linear array.
    Zubrod CG, Schepartz SA, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar; (45):13-4. PubMed ID: 927488
    [No Abstract] [Full Text] [Related]

  • 17. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.
    Venditti JM.
    Cancer Treat Rep; 1983 Sep; 67(9):767-72. PubMed ID: 6883352
    [No Abstract] [Full Text] [Related]

  • 18. Investigational trials of anticancer drugs: establishing safeguards for experimentation.
    Chabner BA, Wittes R, Hoth D, Hubbard S.
    Public Health Rep; 1984 Sep; 99(4):355-60. PubMed ID: 6431482
    [Abstract] [Full Text] [Related]

  • 19. Historical background of the National Cancer Institute's drug development thrust.
    Zubrod CG, Schepartz SA, Carter SK.
    Natl Cancer Inst Monogr; 1977 Mar; (45):7-11. PubMed ID: 337156
    [No Abstract] [Full Text] [Related]

  • 20. Origins and development of chemotherapy research at the National Cancer Institute.
    Zubrod CG.
    Cancer Treat Rep; 1984 Jan; 68(1):9-19. PubMed ID: 6362871
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.